| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.17 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |